Single dose escalation trial of RTU 1096 in volunteers.

Trial Profile

Single dose escalation trial of RTU 1096 in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 May 2015

At a glance

  • Drugs RTU 1096 (Primary)
  • Indications Atopic dermatitis; Psoriasis
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Sponsors R-Tech Ueno
  • Most Recent Events

    • 26 May 2015 Status changed from recruiting to completed according to an R-Tech Uno media release.
    • 25 May 2015 Results published in an R-Tech Uno Media Release.
    • 23 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top